Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.82 USD | -1.63% | -2.24% | -14.76% |
03:25pm | Everlasting momentum | |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.76% | 90.31B | |
+32.85% | 709B | |
+30.77% | 595B | |
-2.40% | 367B | |
+20.07% | 334B | |
+4.99% | 289B | |
+14.34% | 239B | |
+9.08% | 211B | |
-3.84% | 203B | |
+8.76% | 171B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- BMO Capital Downgrades Bristol-Myers Squibb to Market Perform From Outperform, Cuts Price Target to $60 From $70